Amendment No. 2 to Distribution Agreement between Cook Biotech Incorporated and AxoGen Corporation
Cook Biotech Incorporated and AxoGen Corporation have agreed to amend their existing Distribution Agreement. This amendment, effective February 26, 2018, extends the term of the agreement so that it will now continue through June 30, 2027, unless both parties agree to extend it further or terminate it earlier as specified in the agreement. All other terms and conditions of the original agreement remain unchanged.
EXHIBIT 10.5.3
AMENDMENT NO. 2 TO DISTRIBUTION AGREEMENT
Cook Biotech Incorporated, an Indiana Corporation having a place of business at 1425 Innovation place, West Lafayette, Indiana 47906 ("Cook"), and AxoGen Corporation, a Delaware Corporation having a place of business at 13859 Progress Blvd, Alachua, FL 32615 ("Distributor'), hereby amend that certain Distribution Agreement dated August 27, 2008 between them, as amended (collectively, "the Agreement"), as of February 26, 2018 (the " Amendment Date") as follows:
| 1. | ARTICLE X(A) of the Agreement is hereby deleted and replaced in its entirety by the following: |
| A. | The term of this Agreement commences on the Effective Date and continues in full force and effect up through and including June 30, 2027, unless further extended by mutual agreement of the parties or earlier terminated in accordance with this Article X ("Term"). |
Except as specifically modified above, the terms and conditions of the Agreement are unchanged.
Agreed and accepted as of the Amendment Date:
| COOK BIOTECH INCORPORATED | AXOGEN CORPORATION |
|
|
|
| By: /s/ Umesh Patel | By:/s/ Karen Zaderej |
| Printed: Umesh Patel | Printed: Karen Zaderej |
| Title: President | Title: CEO and President |
1
